Literature DB >> 17378798

Prokinetic therapy with erythromycin has no significant impact on blood pressure and heart rate in critically ill patients.

N Q Nguyen, A A Mangoni, R J Fraser, M Chapman, L Bryant, C Burgstad, R H Holloway.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17378798      PMCID： PMC2203248          DOI： 10.1111/j.1365-2125.2006.02772.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

Review 1.  GI complications in patients receiving mechanical ventilation.

Authors:  G M Mutlu; E A Mutlu; P Factor
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

2.  Effect of solid meal on gastric emptying of, and glycemic and cardiovascular responses to, liquid glucose in older subjects.

Authors:  Melanie K Berry; Antonietta Russo; Judith M Wishart; Anne Tonkin; Michael Horowitz; Karen L Jones
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01-02       Impact factor: 4.052

3.  Acute hypotensive effects of oral cisapride and erythromycin in healthy subjects.

Authors:  Arduino A Mangoni; Jacqueline C T Close; Sherylin Rodriguez; Roy A Sherwood; Catherine A Bryant; Cameron G Swift; Stephen H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-08       Impact factor: 4.335

4.  Guidelines for enteral feeding in adult hospital patients.

Authors:  M Stroud; H Duncan; J Nightingale
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

5.  Use of residual volume as a marker for enteral feeding intolerance: prospective blinded comparison with physical examination and radiographic findings.

Authors:  S A McClave; H L Snider; C C Lowen; A J McLaughlin; L M Greene; R J McCombs; L Rodgers; R A Wright; T M Roy; M P Schumer
Journal:  JPEN J Parenter Enteral Nutr       Date:  1992 Mar-Apr       Impact factor: 4.016

Review 6.  Intolerance to intragastric enteral nutrition in critically ill patients: complications and management.

Authors:  R MacLaren
Journal:  Pharmacotherapy       Date:  2000-12       Impact factor: 4.705

7.  Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis.

Authors:  J Tack; J Janssens; G Vantrappen; T Peeters; V Annese; I Depoortere; E Muls; R Bouillon
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

8.  Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding.

Authors:  M J Chapman; R J Fraser; M T Kluger; M D Buist; D J De Nichilo
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

9.  Hypotensive mechanism of [Leu13]motilin in dogs in vivo and in vitro.

Authors:  T Iwai; H Nakamura; H Takanashi; K Yogo; K Ozaki; N Ishizuka; T Asano
Journal:  Can J Physiol Pharmacol       Date:  1998-12       Impact factor: 2.273

10.  Enteral nutrition in the critically ill patient: a prospective survey.

Authors:  D Heyland; D J Cook; B Winder; L Brylowski; H Van deMark; G Guyatt
Journal:  Crit Care Med       Date:  1995-06       Impact factor: 7.598
View more
  4 in total

Review 1.  Pharmacological therapy of feed intolerance in the critically ills.

Authors:  Nam Q Nguyen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

2.  Effects of Fat and Protein Preloads on Pouch Emptying, Intestinal Transit, Glycaemia, Gut Hormones, Glucose Absorption, Blood Pressure and Gastrointestinal Symptoms After Roux-en-Y Gastric Bypass.

Authors:  Nam Q Nguyen; Tamara L Debreceni; Carly M Burgstad; Melissa Neo; Max Bellon; Judith M Wishart; Scott Standfield; Dylan Bartholomeusz; Chris K Rayner; Gary Wittert; Michael Horowitz
Journal:  Obes Surg       Date:  2016-01       Impact factor: 4.129

Review 3.  Current issues on safety of prokinetics in critically ill patients with feed intolerance.

Authors:  Nam Q Nguyen; Swee Lin Chen Yi Mei
Journal:  Ther Adv Drug Saf       Date:  2011-10

4.  Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists.

Authors:  G J Sanger; Y Wang; A Hobson; J Broad
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.